Roswell Park Accelerates CAR T-Cell Innovation with Upcoming Trials - Poll - MDSpire

Roswell Park Accelerates CAR T-Cell Innovation with Upcoming Trials

Renier Brentjens, MD, PhD, has spent most of his career pioneering research into the development and use of CAR T-cell therapies in the hopes of finding innovative and effective treatments for cancer.

  • February 18, 2025

Share

Original Source(s)

Roswell Park Accelerates CAR T-Cell Innovation with Upcoming Trials

  • February 18, 2025

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort